CMTM Family and Gastrointestinal Tract Cancers: A Comprehensive Review

Jie Li1, Xiaozi Wang2, Xiaoning Wang1

  • 1Department of Hematology, Hebei General Hospital, Shijiazhuang, 050000, People's Republic of China.

Insights

The Chemokine-like factor (CKLF)-like MARVEL transmembrane domain-containing family (CMTMs) impacts gastrointestinal cancers. CMTM family members show prognostic value and influence antitumor immunity in these malignancies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Gastrointestinal tract cancers represent a significant global health burden.
  • The Chemokine-like factor (CKLF)-like MARVEL transmembrane domain-containing family (CMTMs) is implicated in various cancers.
  • CMTM family members have demonstrated roles in cancer development, progression, and antitumor immunity.

Purpose of the Study:

  • To systematically review the current literature on the role of the CMTM family in gastrointestinal tract cancers.
  • To highlight the prognostic value and immunological functions of CMTMs in these malignancies.
  • To focus on the specific roles of CMTMs in hepatocellular carcinoma and gastric carcinoma.

Main Methods:

  • Systematic literature review.
  • Analysis of studies investigating CMTM family members in gastrointestinal cancers.
  • Focus on hepatocellular carcinoma and gastric carcinoma research.

Main Results:

  • The CMTM family exhibits significant prognostic potential across multiple cancers.
  • Altered expression of CMTM members correlates with advanced tumor stage, metastasis, and survival outcomes.
  • CMTM proteins are involved in critical aspects of the antitumor immune response.

Conclusions:

  • The CMTM family plays a crucial role in the development and progression of gastrointestinal tract cancers.
  • CMTMs hold promise as prognostic biomarkers and therapeutic targets in gastrointestinal oncology.
  • Further research into CMTM functions can advance understanding of gastrointestinal cancer biology and immunity.